Cargando…

Genomics and clinical correlates of renal cell carcinoma

PURPOSE: Clear cell, papillary cell, and chromophobe renal cell carcinomas (RCCs) have now been well characterised thanks to large collaborative projects such as The Cancer Genome Atlas (TCGA). Not only has knowledge of the genomic landscape helped inform the development of new drugs, it also promis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mitchell, Thomas J., Rossi, Sabrina H., Klatte, Tobias, Stewart, Grant D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Topic Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280817/ https://www.ncbi.nlm.nih.gov/pubmed/30099580 http://dx.doi.org/10.1007/s00345-018-2429-x

Ejemplares similares

Quality of life outcomes in patients with localised renal cancer: a literature review
por: Rossi, Sabrina H., et al.
Publicado: (2018)

Screening programs for renal cell carcinoma: a systematic review by the EAU young academic urologists renal cancer working group
por: Diana, Pietro, et al.
Publicado: (2022)

Epidemiology and screening for renal cancer
por: Rossi, Sabrina H., et al.
Publicado: (2018)

Imaging for the diagnosis and response assessment of renal tumours
por: Rossi, Sabrina H., et al.
Publicado: (2018)

Antibody therapy in renal cell carcinoma
por: Oosterwijk, Egbert, et al.
Publicado: (2008)

WHO/ISUP classification, grading and pathological staging of renal cell carcinoma: standards and controversies
por: Warren, Anne Y., et al.
Publicado: (2018)

Targeted therapy in renal cell carcinoma: moving from molecular agents to specific immunotherapy
por: Bedke, Jens, et al.
Publicado: (2013)

Ultrasound-based “CEUS-Bosniak”classification for cystic renal lesions: an 8-year clinical experience
por: Herms, Elena, et al.
Publicado: (2022)

Systemic therapy in metastatic renal cell carcinoma (mRCC): an evidence-based recommendation of the German interdisciplinary RCC guidelines group
por: Grünwald, V., et al.
Publicado: (2022)

Adherence to guideline recommendations for management of clinical T1 renal cancers in the Netherlands: a population-based study
por: Aben, Katja K. H., et al.
Publicado: (2016)

Staging of renal cell carcinoma: Current concepts
por: Lam, John S., et al.
Publicado: (2009)

Available ablation energies to treat cT1 renal cell cancer: emerging technologies
por: Zondervan, P. J., et al.
Publicado: (2018)

Diagnostics and prognostic evaluation in renal cell tumors: the German S3 guidelines recommendations
por: Junker, Kerstin, et al.
Publicado: (2022)

Experimental rat bladder urothelial cell carcinoma models
por: Arentsen, Harm C., et al.
Publicado: (2009)

Predicting invasiveness and disease-specific survival in upper tract urothelial carcinoma: identifying relevant clinical tumour characteristics
por: Malm, Camilla, et al.
Publicado: (2019)

Clinical characteristics, treatment patterns and relapse in patients with clinical stage IS testicular cancer
por: Brandt, Maximilian Peter, et al.
Publicado: (2021)

The heat is on: the impact of excessive temperature increments on complications of laser treatment for ureteral and renal stones
por: Tonyali, Senol, et al.
Publicado: (2023)

Consultation on UTUC, Stockholm 2018 aspects of diagnosis of upper tract urothelial carcinoma
por: Fojecki, Grzegorz, et al.
Publicado: (2019)

Local Treatment of Recurrent Renal Cell Carcinoma May Have a Significant Survival Effect Across All Risk-of-recurrence Groups
por: Marconi, Lorenzo, et al.
Publicado: (2022)

Volumetric imaging: a potential tool to stage upper tract urothelial carcinoma
por: Grahn, Alexandra, et al.
Publicado: (2019)

Detection of specific chromosomal aberrations in urine using BCA-1 (oligo-CGH-array) enhances diagnostic sensitivity and predicts the aggressiveness of non-muscle-invasive bladder transitional cell carcinoma
por: Cussenot, Olivier, et al.
Publicado: (2013)

Prognostic impact of molecular muscle-invasive bladder cancer subtyping approaches and correlations with variant histology in a population-based mono-institutional cystectomy cohort
por: Weyerer, Veronika, et al.
Publicado: (2021)

Proteomic profiling of cisplatin-resistant and cisplatin-sensitive germ cell tumour cell lines using quantitative mass spectrometry
por: Fichtner, A., et al.
Publicado: (2022)

Global change of surgical and oncological clinical practice in urology during early COVID-19 pandemic
por: Dotzauer, Robert, et al.
Publicado: (2020)

Intravesical hyperthermia and mitomycin-C for carcinoma in situ of the urinary bladder: experience of the European Synergo(®) working party
por: Alfred Witjes, J., et al.
Publicado: (2009)

No Residual Basal Cell Carcinoma after Excision for Biopsy-proven Tumor: Clinical and Medicolegal Implications
por: Gurunluoglu, Raffi, et al.
Publicado: (2014)

Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysis
por: Mori, Keiichiro, et al.
Publicado: (2022)

Urological cancer care pathways: development and use in the context of systematic reviews and clinical practice guidelines
por: MacLennan, Sara Jane, et al.
Publicado: (2011)

Testicular germ cell tumours’ clinical stage I: comparison of surveillance with adjuvant treatment strategies regarding recurrence rates and overall survival—a systematic review
por: Ruf, Christian G., et al.
Publicado: (2022)

Renal Cell Carcinoma with Sarcomatoid Features: Finally New Therapeutic Hope?
por: Pichler, Renate, et al.
Publicado: (2019)

Utility of pT3 substaging in lymph node-negative urothelial carcinoma of the bladder: do pathologic parameters add to prognostic sub-stratification?
por: Maas, Moritz, et al.
Publicado: (2021)

Associations of serum levels of microRNA-371a-3p (M371) with risk factors for progression in nonseminomatous testicular germ cell tumours clinical stage 1
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2021)

Performance of clinical risk scores and prediction models to identify pathogenic germline variants in patients with advanced prostate cancer
por: Rebhan, Katharina, et al.
Publicado: (2023)

Therapy of clinical stage IIA and IIB seminoma: a systematic review
por: Heinzelbecker, Julia, et al.
Publicado: (2021)

Clinical trials in urological oncology: COVID-19 and the potential need for a new perspective
por: Teh, Jiasian, et al.
Publicado: (2020)

The clinical value of the Tei index among Nigerians with hypertensive heart failure: correlation with other conventional indices
por: Akintunde, AA
Publicado: (2012)

Evaluation of the draft guidelines proposed by EMA and FDA for the clinical diagnosis of acute uncomplicated cystitis in women
por: Alidjanov, Jakhongir F., et al.
Publicado: (2019)

Prognostic factors in patients with clinical stage I nonseminoma—beyond lymphovascular invasion: a systematic review
por: Zengerling, Friedemann, et al.
Publicado: (2022)

Dysrhythmogenic potential in acute admissions to psychiatric hospitals and clinics
por: Grant, CC, et al.
Publicado: (2007)

The 2018 correlative microscopy techniques roadmap
por: Ando, Toshio, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bgm0jee0mqemjag1rptiul1mk1